Development Level

Tbio 5 | 10,625

Disease

glioblastoma 5 | 5,572
Multiple myeloma 4 | 1,327
medulloblastoma, large-cell 4 | 6,234
osteosarcoma 4 | 7,933
ovarian cancer 4 | 8,484
pediatric high grade glioma 4 | 2,712
psoriasis 4 | 6,685
atypical teratoid / rhabdoid tumor 3 | 4,369
ependymoma 3 | 2,514
lung cancer 3 | 4,466
primitive neuroectodermal tumor 3 | 3,031
Amyotrophic Lateral Sclerosis 2 | 431
Breast cancer 2 | 3,094
Carcinoma 2 | 2,147
Influenza 2 | 142
Waldenstrons macroglobulinemia 2 | 765
astrocytoma 2 | 1,493
atypical teratoid/rhabdoid tumor 2 | 1,095
dermatomyositis 2 | 933
group 4 medulloblastoma 2 | 1,875
lung adenocarcinoma 2 | 2,713
nasopharyngeal carcinoma 2 | 1,056
oligodendroglioma 2 | 2,849
Acrocallosal syndrome 1 | 12
Allergic rhinitis 1 | 91
Astigmatism 1 | 27
CHARGE syndrome 1 | 23
Cancer 1 | 2,346
Clubfoot 1 | 35
Corneal edema 1 | 14
Frontotemporal dementia 1 | 41
Gaucher disease type 1 1 | 171
Greig cephalopolysyndactyly syndrome 1 | 3
HIV Infections 1 | 100
Holoprosencephaly 1 | 52
Hypopigmentation disorder 1 | 2
Hypothalamic hamartomas 1 | 1
Imperforate anus 1 | 14
Keratitis 1 | 42
Keratoconus 1 | 47
Keratopathy 1 | 12
Kidney cancer 1 | 118
Neural Tube Defects 1 | 27
POLYDACTYLY, POSTAXIAL 1 | 1
POSTAXIAL POLYDACTYLY, TYPE B 1 | 1
Pallister-Hall syndrome 1 | 11
Polydactyly 1 | 93
Polydactyly, preaxial 4 1 | 1
Postaxial polydactyly type A 1 | 1
Prostatic Neoplasms 1 | 471
Pseudopterygium 1 | 1
Pyelonephritis 1 | 12
Rett syndrome 1 | 18
Status Epilepticus 1 | 85
Stomach Neoplasms 1 | 282
Synostosis 1 | 18
acute myeloid leukemia 1 | 780
acute quadriplegic myopathy 1 | 1,157
adrenocortical carcinoma 1 | 1,427
astrocytic glioma 1 | 2,241
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 499
colon cancer 1 | 1,475
cutaneous lupus erythematosus 1 | 1,056
diabetes mellitus 1 | 1,663
gastric carcinoma 1 | 832
group 3 medulloblastoma 1 | 2,254
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
juvenile dermatomyositis 1 | 1,189
lung carcinoma 1 | 2,844
medulloblastoma 1 | 1,524
mucosa-associated lymphoid tissue lymphoma 1 | 480
non primary Sjogren syndrome sicca 1 | 840
non-small cell lung cancer 1 | 2,798
pilocytic astrocytoma 1 | 3,086
posterior fossa group B ependymoma 1 | 1,530
primary Sjogren syndrome 1 | 789
sonic hedgehog group medulloblastoma 1 | 1,482
subependymal giant cell astrocytoma 1 | 2,287
systemic lupus erythematosus 1 | 156
tuberculosis and treatment for 6 months 1 | 686

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146
Kinase 1 | 634
Transcription Factor 1 | 1,400

Grant Application

5R01AI034552-11 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin enhancer-binding factor 2 ILF2 Tbio Non-IDG -1.51960 36.4 249
Interleukin enhancer-binding factor 3 ILF3 Tbio Non-IDG -2.09543 135.8 239
Transcriptional activator GLI3 GLI3 Tbio Transcription Factor -3.17963 1388.1 188
ATP-dependent RNA helicase A DHX9 Tbio Enzyme -2.80890 693.7 191
Interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2 Tbio Kinase -1.92221 85.7 805